急诊科丙泊酚靶控输注镇静(ProTEDS):一项多中心单臂可行性研究
该多中心单臂可行性研究在苏格兰4个急诊科纳入25例18-65岁、体重≥50kg、禁食≥90min的前肩关节脱位患者,采用丙泊酚靶控输注(TCI)辅助复位。主要终点患者满意度VAS均值97±9(14例有记录),20例达到OAA/S 3的充分镇静且全部复位成功,镇静时间25±8min,无不良事件。招募率仅20%,低于预期。结论认为丙泊酚TCI作为急诊程序性镇静方法可被患者接受,但开展RCT需专门研究支持。
要点
- 适用人群:18-65岁前肩关节脱位、体重≥50kg、禁食≥90min的急诊患者。
- 20例达OAA/S 3充分镇静,全部复位成功;镇静时间25±8min。
- 患者满意度VAS均值97±9(14例记录),无不良事件(采用SIVA不良事件报告工具)。
- 16个月招募25例,招募率20%,低于预期,需专门研究支持。
- 该研究为单臂可行性研究,不能证明TCI优于bolus推注。
适用人群与场景
- 苏格兰4个急诊科中18-65岁、前肩关节脱位、体重≥50kg、禁食≥90min的患者。
诊断标准与关键阈值
- 充分镇静定义为改良观察者警觉/镇静评估量表(OAA/S)3分。
处置流程与药物剂量
- 第一步:筛选符合条件的前肩关节脱位患者。
- 第二步:使用丙泊酚靶控输注(TCI)进行程序性镇静,目标为OAA/S 3。
- 第三步:在充分镇静下进行肩关节复位。
- 原文未提及丙泊酚的具体剂量、单位、给药频次或疗程。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:多中心单臂可行性研究;4个急诊科;25例招募,2例排除。
- 干预:丙泊酚TCI用于前肩关节脱位复位镇静;无对照组。
- 主要终点:患者满意度VAS均值97±9(14例有记录)。
- 关键结果:20例达OAA/S 3充分镇静,全部复位成功;镇静时间25±8min;无不良事件(SIVA工具)。
- 招募率20%(16个月招募窗口),低于预期。
证据类型、等级与局限
- 证据类型:单臂可行性研究(非RCT)。
- 局限:单臂、无对照、样本量小(25例)、满意度仅14例记录、招募率低。
对床旁实践的改变
- 丙泊酚TCI可作为急诊程序性镇静的可接受方法,但需在符合条件的患者中使用。
- 该研究不能改变现有bolus推注的常规做法,因无对照比较。
- 招募率低提示未来RCT需专门研究支持。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Procedural sedation is a core skill of the emergency physician. Bolus administration of propofol is widely used in UK EDs. Titrated to an end point of sedation, it has a rapid effect but has been associated with adverse incidents. The use of a target-controlled infusion (TCI) of propofol is not routine but may reduce the incidence of adverse incidents.The primary aims of this single-arm feasibility study were patient satisfaction and to establish recruitment rates for a randomised controlled trial comparing propofol TCI to bolus administration.
METHODS: Four EDs in Scotland, UK, participated. Patients aged 18-65 years, with anterior shoulder dislocation, weight ≥ 50kg, fasted ≥ 90 min were screened. Patients underwent reduction of their dislocated shoulder using TCI propofol. The primary end point was patient satisfaction recorded on a Visual Analogue Scale.
RESULTS: Between 3 April 2017 and 31 December 2018, 25 patients were recruited with a recruitment rate of 20% for the 16-month recruitment window, with a temporary pause to allow amendment of drug dosage.Two patients were excluded. Twenty achieved adequate sedation, defined as a Modified Observer's Assessment of Alertness/Sedation Scale (OAA/S) 3. Successful reduction was achieved in all adequately sedated. Patient satisfaction was documented in 14 patients, mean±SD of 97±9 and time to sedation was 25±8 min. No adverse events were recorded using the Society of Intravenous Anaesthesia adverse event reporting tool.
CONCLUSION: Propofol TCI was acceptable as a method of procedural sedation for patients. The lower than expected recruitment rates highlight the need for dedicated research support.
TRIAL REGISTRATION NUMBER: NCT03442803.
参考来源
- Burton FM, Lowe DJ, Millar J, et al. Propofol Target-Controlled Infusion in Emergency Department Sedation (ProTEDS): a multicentre, single-arm feasibility study. Emerg Med J. 2020. PMID: 33298604. doi:10.1136/emermed-2020-209686
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。